Premium
ERBB3 kinase domain mutations are rare in lung, breast and colon carcinomas
Author(s) -
Jeong Eun Goo,
Soung Young Hwa,
Lee Jong Woo,
Lee Sung Hak,
Nam Suk Woo,
Lee Jung Young,
Yoo Nam Jin,
Lee Sug Hyung
Publication year - 2006
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.22257
Subject(s) - cancer research , erbb3 , receptor tyrosine kinase , tyrosine kinase , erlotinib , erbb , gefitinib , protein kinase domain , erbb4 , biology , cyclin dependent kinase 4 , medicine , kinase , epidermal growth factor receptor , cancer , signal transduction , cyclin dependent kinase 2 , protein kinase a , microbiology and biotechnology , genetics , mutant , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom